Financial Analysis: Aeon Global Health (OTCMKTS:AGHC) & Organon & Co. (NYSE:OGN)

Aeon Global Health (OTCMKTS:AGHC) and Organon & Co. (NYSE:OGN) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership.

Insider and Institutional Ownership

77.4% of Organon & Co. shares are owned by institutional investors. 11.5% of Aeon Global Health shares are owned by company insiders. Comparatively, 1.4% of Organon & Co. shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Aeon Global Health and Organon & Co., as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aeon Global Health	0	0	0	0	0.00
Organon & Co.	2	2	1	1	2.17

Organon & Co. has a consensus price target of $13.00, indicating a potential upside of 98.90%. Given Organon & Co.’s stronger consensus rating and higher probable upside, analysts plainly believe Organon & Co. is more favorable than Aeon Global Health.

Profitability

This table compares Aeon Global Health and Organon & Co.’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aeon Global Health	N/A	N/A	N/A
Organon & Co.	11.15%	163.88%	6.99%

Earnings & Valuation

This table compares Aeon Global Health and Organon & Co.”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aeon Global Health	N/A	N/A	N/A	N/A	N/A
Organon & Co.	$6.40 billion	0.27	$864.00 million	$2.69	2.43

Organon & Co. has higher revenue and earnings than Aeon Global Health.

Summary

Organon & Co. beats Aeon Global Health on 9 of the 10 factors compared between the two stocks.

About Aeon Global Health

AEON Global Health Corp. is a growth oriented provider of personalized, actionable medical informatics, and telemedicine. It offers a comprehensive menu of diagnostic and laboratory developed assays, as well as interpretive data for a range of inherited conditions. The company was founded by Hanif A. Roshan and Shawn Desai in August 1985 and is headquartered in Gainesville, GA.

About Organon & Co.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.